| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6189418 | Brachytherapy | 2014 | 9 Pages |
Abstract
MRI-guided high-dose-rate prostate brachytherapy focal tumor boost is feasible-tumor regions can be identified even after hormone therapy, and focal boost dose can be delivered without violating urethral and rectal dose constraints.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Josh Mason, Bashar Al-Qaisieh, Peter Bownes, Dan Wilson, David L. Buckley, David Thwaites, Brendan Carey, Ann Henry,